Brokers Set Expectations for Elevance Health FY2025 Earnings

Elevance Health, Inc. (NYSE:ELV) – Equities research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Elevance Health in a note issued to investors on Friday, January 24th. Cantor Fitzgerald analyst S. James now expects that the company will post earnings per share of $34.57 for the year, down from their previous estimate of $34.65. Cantor Fitzgerald has a “Overweight” rating and a $485.00 price target on the stock. The consensus estimate for Elevance Health’s current full-year earnings is $32.95 per share.

Elevance Health (NYSE:ELV) last posted its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.80 by $0.04. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%.

Other equities research analysts also recently issued research reports about the company. Royal Bank of Canada lowered their price target on Elevance Health from $585.00 to $478.00 and set an “outperform” rating on the stock in a research report on Friday, October 18th. Stephens cut Elevance Health from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $520.00 to $440.00 in a research note on Wednesday, January 22nd. Truist Financial dropped their price objective on Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a research note on Monday, January 6th. StockNews.com downgraded shares of Elevance Health from a “buy” rating to a “hold” rating in a research note on Monday. Finally, Argus cut shares of Elevance Health from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. Four research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Elevance Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $525.60.

Elevance Health Trading Up 2.5 %

NYSE ELV opened at $411.14 on Monday. The stock’s 50-day simple moving average is $386.21 and its two-hundred day simple moving average is $461.36. Elevance Health has a twelve month low of $362.21 and a twelve month high of $567.26. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $95.35 billion, a price-to-earnings ratio of 14.99, a PEG ratio of 1.11 and a beta of 0.84.

Institutional Trading of Elevance Health

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Cypress Wealth Services LLC grew its holdings in Elevance Health by 3.5% during the 3rd quarter. Cypress Wealth Services LLC now owns 679 shares of the company’s stock valued at $353,000 after purchasing an additional 23 shares during the last quarter. Atomi Financial Group Inc. boosted its position in Elevance Health by 4.2% in the 3rd quarter. Atomi Financial Group Inc. now owns 615 shares of the company’s stock valued at $320,000 after buying an additional 25 shares during the period. Lifeworks Advisors LLC boosted its position in Elevance Health by 2.5% in the 3rd quarter. Lifeworks Advisors LLC now owns 1,037 shares of the company’s stock valued at $539,000 after buying an additional 25 shares during the period. Catalyst Financial Partners LLC boosted its position in Elevance Health by 2.9% in the 3rd quarter. Catalyst Financial Partners LLC now owns 918 shares of the company’s stock valued at $477,000 after buying an additional 26 shares during the period. Finally, Fullcircle Wealth LLC boosted its position in Elevance Health by 1.5% in the 3rd quarter. Fullcircle Wealth LLC now owns 1,743 shares of the company’s stock valued at $906,000 after buying an additional 26 shares during the period. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

Elevance Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be issued a $1.71 dividend. The ex-dividend date of this dividend is Monday, March 10th. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 annualized dividend and a yield of 1.66%. Elevance Health’s dividend payout ratio (DPR) is 23.77%.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.